Low prevalence of hepatitis C virus infection in Amerindians from Western Venezuela
AUTOR(ES)
Monsalve-Castillo, Francisca, Chacín-Bonilla, Leonor, Atencio, Ricardo J, Espinoza, Leticia Porto, Costa-León, Luciana, Echevarría, José M
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2007-02
RESUMO
Previous studies have not found hepatitis C virus (HCV) infection in Amerindians from Western Venezuela. A survey of 254 Bari and Yukpa natives aged 10-60 years (mean ± SD age = 35 ± 5.4 years) from four communities, two Bari and two Yukpa, in this area were studied to assess the prevalence of antibodies to HCV (anti-HCV) and HCV RNA among these indigenous populations. Serum samples were examined initially for anti-HCV by a four generation enzyme-linked immunosorbent assay (ELISA). Reactive samples were then tested using a third generation recombinant immunoblot assay (RIBA-3). Viral RNA was investigated in all immunoblot-reactive samples by a nested polymerase chain reaction (PCR) method. Six (2.3%) of 254 natives were positive by ELISA, one (2.2%) of these reactive samples were positive by RIBA, and four (1.5%) were indeterminate. Only two (0.8%) were positive by PCR, corresponding to 1 (2.1%) of 47 inhabitants of a Yukpa community and to 1 (2.2%) of 45 subjects of a Bari community. Iatrogenic is thought to play a role in acquisition of the infection. The findings indicate a HCV focus of low endemicity and are compatible with a low degree of exposures of the natives to the virus. Studies are necessary to assess the risk factors for infection in these Amerindians.
Documentos Relacionados
- Antigenic Diversity of Hepatitis B Virus Strains of Genotype F in Amerindians and Other Population Groups from Venezuela
- Low prevalence of human immunodeficiency virus and hepatitis C virus co-infection in a medium size city in southern Brazil
- Prevalence of hepatitis C Virus infection among hemophiliacs in Central Brazil
- Hepatitis G Virus Infection in Amerindians and Other Venezuelan High-Risk Groups
- Prevalence and risk factors of hepatitis C virus infection in hemodialysis patients from one center in Recife, Brazil